Clinical Trial Update: A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting [Phase 3]

View source ↗

Summary

A Phase 3 trial update evaluating adalimumab for ulcerative colitis in US clinical practice, focusing on quality of life, healthcare utilization, and costs; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Adalimumab (Humira) (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2016-11-01